Patents

1.

1/12/16 – Received US Patent US 9,233,119 B2 entitled:

USE OF HMGA-TARGETED PHOSPHOROTHIOATE DNA APTAMERS TO SUPPRESS CARCINOGENIC ACTIVITY AND INCREASE SENSITIVITY TO CHEMOTHERAPY AGENTS IN HUMAN CANCER CELLS

Applicant – Miami University

Inventor – Michael A. Kennedy

2.

7/20/16 - Received US Divisional Patent 9,492,470 entitled:

USE OF HMGA-TARGETED PHOSPHOROTHIOATE DNA APTAMERS TO SUPPRESS CARCINOGENIC ACTIVITY AND INCREASE SENSITIVITY TO CHEMOTHERAPY AGENTS IN HUMAN CANCER CELLS

Applicant – Miami University

Inventor – Michael A. Kennedy

3.

10/27/20 – Received US Patent US 10,813,957 B2

Engineered Oncolytic Viruses Containing Hyper-Binding Sites To Sequester And Suppress Activity Of Oncogenic Transcription Factors As A Novel Treatment For Human Cancer

Applicant – Miami University

Inventor – Michael A. Kennedy